Full Event Guide

Take a look at the full agenda built with thought leaders from Legend Bio, Seattle GeneticsPrecision BiosciencesKite Pharma and many more developing next generation BCMA targeted therapies from bench to bedside for the treatment of multiple myeloma.

Gain an understanding of bispecific T-cell engagers from those leading BCMA BiTe clinical trials, discuss the rationale of combination studies and review the leading anti-BCMA CAR-TCRs with live clinical updates taking you one step closer to understanding this competitive landscape.

BCMA June Front Cover